In the evolving landscape of animal disease prevention, the ability to rapidly and accurately identify pathogens has become crucial for safeguarding animal health and public safety. Among these threats, the Influenza A Virus stands out for its high mutation rate and potential for cross-species transmission, posing significant risks to poultry, swine, equine populations, and ultimately human health.
The Challenge of Influenza A Virus in Animal Populations
As a member of the Orthomyxoviridae family, Influenza A Virus exhibits remarkable genetic diversity and variability. The virus contains a single-stranded RNA genome surrounded by a lipid envelope. Classification into subtypes is based on the antigenic properties of hemagglutinin (HA) and neuraminidase (NA), with 16 known HA subtypes and 9 NA subtypes currently identified.
Viral strains demonstrate varying pathogenicity, ranging from low pathogenic avian influenza viruses (LPAIV) to highly pathogenic forms (HPAIV). Waterfowl serve as natural reservoirs for LPAIV, while HPAIV outbreaks, particularly those involving H5 and H7 subtypes, can cause devastating poultry epidemics with substantial economic consequences. Additionally, subtypes like H1N1, H1N2, and H3N2 cause respiratory infections in swine populations, while H3N8 affects horses, collectively representing significant animal health concerns.
The virotype Influenza A 2.0 RT-PCR Kit: A Technological Leap Forward
The newly developed virotype Influenza A 2.0 RT-PCR Kit (FLI-C 116) addresses critical limitations in current animal influenza virus detection methods through integrated design and optimized workflows, significantly enhancing laboratory efficiency and diagnostic accuracy.
Enhanced Efficiency: Accelerating Diagnostic Timelines
Superior Performance Characteristics
Versatile Sample Applications
The kit has been validated for diverse sample types across multiple species:
The high sensitivity permits pooled testing of up to 10 individual swab samples, significantly enhancing efficiency during large-scale surveillance operations.
Quality Assurance and Support Infrastructure
The manufacturer maintains ISO 9001:2015 certification for all development, production, and quality control processes. The product line benefits from established supply chain reliability, with consistent production capacity and strategic inventory management to ensure availability during peak demand periods.
Technical support includes access to veterinary diagnostic specialists for comprehensive guidance spanning product selection, experimental implementation, and result analysis.
Comprehensive Diagnostic Ecosystem
The system integrates with complementary products for complete diagnostic workflows, including automated nucleic acid extraction solutions and specialized assays for other significant animal pathogens such as PRRSV, BTV, and various Mycoplasma species.
All products undergo rigorous quality validation and comply with regional regulatory requirements. Product availability may vary by jurisdiction, with certain applications restricted to research use in specific markets.
Contact Person: Mr. Huang Jingtai
Tel: 17743230916